Language Switch - Cryo-Cell Website in Spanish
Cryo-Cell Contact Number

Company Overview

 

Pride in our people, our practices
and our potential to save lives.

Cryo-Cell International, Inc. was established in 1989 with a primary focus on the cryopreservation of umbilical cord (Umbilical Cord Blood Stem Cells) stem cells for family use. Since our inception, we have been committed to the development and adoption of industry best practices and technologies.

Ever-committed to the highest quality, we treat every specimen of umbilical cord blood as if it were our own. Every sample we receive, process and preserve represents a potentially life-saving treatment for a child. This concept fuels our resolve to only hire the most talented candidates, develop and implement the most effective training and continuously fine-tune our processes. From the design and specifications of our collection kit, to the choice of each supplier, our dedication to quality remains unwavering.

Saneron CCEL Therapeutics, Inc.

Cryo-Cell holds an equity position in Saneron CCEL Therapeutics (Saneron), a University of South Florida spin-out biotechnology company. Saneron is committed to advancing research using readily available, non-controversial cord blood stem cells. Saneron’s research focus is to actively seek new cellular therapy discoveries for treatment of and intervention in devastating, life-threatening illness and conditions such as heart attack, Alzheimer’s disease, stroke, and spinal cord injury. For more information, visit Saneron’s Web site: www.saneron-ccel.com

Back to top of page
Enroll Now